Search

everythinglearnresearchcommunity

for

Search:↓

Two types of 5α-reductase are in dog skin, which might make dutasteride better than finasteride for treating dog hair loss.

The conclusion is that PCOS is a common cause of hirsutism in young obese women, and early treatment is important to reduce the risk of metabolic syndrome.

Spironolactone may help reduce hair loss in androgenic alopecia.

Altered metabolism can help control seizures by changing brain signaling and energy use, suggesting new treatments for epilepsy.

The document concludes that hair loss is influenced by genetics and other factors, and while treatments like finasteride can help, they have limitations and side effects.

Managing emotional distress, obesity, insulin resistance, and high male hormones is crucial for improving well-being in women with PCOS.

PCOS affects many women, causing various symptoms and health risks, and is managed through lifestyle changes, medication, and support groups.

Doctors should recognize and treat PCOS early in primary care to manage symptoms and lower risk of other health issues.

Different substances that activate or block the androgen receptor can affect male development and treat conditions like prostate cancer.

Identifying nonclassic congenital adrenal hyperplasia and carriers of CYP21 mutations is challenging, and genetic counseling is recommended due to their prevalence.

The document concludes that hirsutism can be managed with various treatments tailored to the individual, potentially improving quality of life.

Cernitin™, a pollen extract, was found to significantly reduce pain and inflammation in rats with chronic prostatitis, suggesting it could be a useful alternative to certain anti-inflammatory drugs.

Hormonal therapies are effective for managing hair and skin symptoms in women with PCOS.

Scientists successfully created and analyzed the structure of a part of the human androgen receptor with specific modulators and a peptide to understand how it binds differently in various tissues.

Recognizing and managing hirsutism, alopecia, and acne is crucial for improving wellbeing in women with PCOS.

PCOS is linked to a higher risk of endometrial cancer but not ovarian or breast cancer, and more research is needed on its role in cancer development and treatment effects.

Estrogens and progesterone are key in regulating melasma pigmentation.

Obesity significantly affects skin health, causing conditions like acanthosis nigricans and skin tags, and should be considered during skin exams.

Skin problems like excessive hair growth, acne, and dark skin patches can be signs of Polycystic Ovarian Disease, which may also be linked to family history and a risk for diabetes.

Diagnosing and treating PCOS is complex due to differing criteria and requires a team approach.

A thorough initial check-up is essential before sperm banking to ensure the best chance of preserving good quality sperm.

The document concludes that treatments for female hair loss and excess body hair are available, but managing expectations is important.

The document concludes that managing PCOS involves lifestyle changes, medication, and monitoring for associated health risks.

Androgen levels do not determine the type of PCOS symptoms in young females.

Teens with PCOS have a higher risk of type 2 diabetes and need regular glucose checks.

Aldactone effectively reduces hair thickness in women with excessive hair growth, both alone and with other treatments.

Spironolactone effectively makes hair shafts thinner in women with excessive hair growth.

PCOS may have evolved as an advantage in past environments with food scarcity.

Testosterone therapy can help postmenopausal women with low sexual desire but needs more safety research and should be used with estrogen therapy.

Testosterone therapy can help with androgen deficiency in women but should be used with caution and monitoring due to potential risks.